Cover Image

Analysis of the communication of adverse events from the perspective of the nurses directly involved in patient care

This descriptive study aimed to analyze the process of communicating adverse events in the hospital context, from the nurses' perspective. Data was collected in January 2013 in a public hospital in Fortaleza, Ceará, Brazil. A semi-structured interview was held with 37 nurses, covering guiding...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ilse Maria Tigre de Arruda Leitão (Author), Roberta Meneses Oliveira (Author), Sarah de Sá Leite (Author), Marina Castro Sobral (Author), Sarah Vieira Figueiredo (Author), Mariana Correia Cadete (Author)
Format:	Book
Published:	Universidade Federal do Ceará, 2014-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ANÁLISE DA COMUNICAÇÃO DE EVENTOS ADVERSOS NA PERSPECTIVA DE ENFERMEIROS ASSISTENCIAIS
by: Ilse Maria Tigre de Arruda Leitão, et al.
Published: (2013)

Estratégias para promover segurança do paciente: da identificação dos riscos às práticas baseadas em evidências
by: Roberta Meneses Oliveira, et al.
Published: (2014)

Comunicação terapêutica em Enfermagem: instrumento essencial do cuidado Comunicación terapéutica en Enfermería: herramienta esencial de la atención Therapeutic communication in Nursing: essential instrument of care
by: Alexandra Carvalho Pontes, et al.
Published: (2008)

Direct medical costs of adverse events in Dutch hospitals
by: Asscheman Henk, et al.
Published: (2009)

Systemic Adverse Events Associated with Locally Administered Corticosteroids
by: Femke De Vleeschhauwer, et al.
Published: (2024)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021)

NURSING AND INTERNATIONAL SAFETY GOALS: HEMODIALYSIS ASSESSMENT
by: Letícia Lima Aguiar, et al.
Published: (2017)

Adverse Events Related to Direct-To-Consumer Sequential Aligners-A Study of the MAUDE Database
by: Priyanka Belgal, et al.
Published: (2023)

Vemurafenib and cutaneous adverse events - report of five cases
by: Giselle de Barros Silva, et al.
Published: (2015)

Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
by: Ali AK
Published: (2011)

Cardiovascular adverse events associated with oral antineoplastic therapy
by: Jacqueline Mota da Silva, et al.

Diagnósticos de enfermagem presentes em pacientes adultos no pós-operatório de cirurgia cardíaca
by: Sherida Karanini Paz de Oliveira1 , Francisca Elisângela Teixeira Lima2 , Ilse Maria Tigre de Arruda Leitão3 , Larissa Bento de Araújo Mendonça4 , Lídia Stella Teixeira de Meneses5 , Roberta Meneses Oliveira6
Published: (2020)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

NURSES' KNOWLEDGE ABOUT ADVERSE EVENTS AND THE CHALLENGES OF REPORTING THESE EVENTS
by: Jamilly Santos Araujo, et al.
Published: (2016)

ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE ELDERLY
by: Lúcia Helena Linheira-Bisetto, et al.
Published: (2016)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
by: Flavia Giron Camerini, et al.
Published: (2013)

Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021
by: Anthony Martinez, et al.
Published: (2023)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Adverse Events Following Immunization
by: L.I. Chernyshova
Published: (2014)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022)

Reporting adverse events in a hospital environment from the perspective of nursing professionals
by: Ramini Pietra de Ávila Ferreira Costa, et al.
Published: (2024)

Incidents and adverse events notified at hospital level
by: Andreia Mascarello, et al.
Published: (2021)

Mortality and years of life lost related to adverse drug events in Brazil
by: Lunara Teles Silva, et al.
Published: (2024)

Evaluating the intervening factors in patient safety: focusing on hospital nursing staff
by: Roberta Meneses Oliveira, et al.
Published: (2015)

COVID-19 postvaccination adverse events and vaccine hesitancy among hospital employees: Is there a link?
by: Anastasiia Weiland, et al.
Published: (2022)

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon
by: Abeer Zeitoun, et al.
Published: (2024)

Tensions and paradoxes in health involving rights, knowledge and trust: mapping the debate and pointing to directions of research
by: Tiago Correia

Severity and workload related to adverse events in the ICU
by: Clarita Terra Rodrigues Serafim, et al.

Adverse events related to the use of enteral nutritional therapy
by: Anamarta Sbeghen Cervo, et al.

The reasons of the nursing staff to notify adverse events
by: Miriam Cristina Marques da Silva de Paiva, et al.
Published: (2014)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2024)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database
by: Yanjing Zhang, et al.
Published: (2024)